Financial Statements - Solvay
Financial Statements - Solvay
Financial Statements - Solvay
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
16<br />
<strong>Solvay</strong> Global Annual Report 2008<br />
Energy situation<br />
During the fi rst part of 2008, energy prices soared, before<br />
falling suddenly during the second half in the wake of the<br />
global economic crisis.<br />
The <strong>Solvay</strong> group’s energy bill rose noticeably in 2008,<br />
though the Group’s proactive energy policy kept the rise<br />
well below that of market prices. The 2008 net energy bill<br />
represents 10% of sales, compared with 8% in 2007.<br />
The key features of the Group’s energy policy are<br />
improving the energy effi ciency of its industrial processes,<br />
diversifying energy sources, using cogeneration and<br />
renewable energies, and setting up partnerships and<br />
energy integration projects.<br />
In 2008 this policy took concrete form in the decision<br />
to build a cogeneration unit using secondary fuels<br />
on the Bernburg (Germany) site in partnership with<br />
Tönsmeier and a cogeneration unit supplied by biomass<br />
on the Tavaux (France) site, in partnership with Dalkia.<br />
In Argentina, <strong>Solvay</strong> Indupa has secured a supply of<br />
competitively priced energy by partnering with a local<br />
energy group to build an electricity generating plant on its<br />
Bahia Blanca site.<br />
Depending on the specifi c market conditions of each<br />
activity, price rises are also negotiated to compensate the<br />
rise in energy costs.<br />
In response to the rapidly-evolving energy situation,<br />
<strong>Solvay</strong> announced in 2008 the creation of a dedicated<br />
subsidiary with the primary objective of supplying and<br />
covering the main energy needs (electricity, gas, coal,<br />
coke, etc.) of its Sectors and SBUs.<br />
Comments on the key fi gures<br />
Income statement<br />
Non-recurring items amounted to EUR 20 million in<br />
2008 compared with EUR 31 million in 2007.<br />
These include:<br />
– the reversal of the impairment on the trona mine<br />
(natural soda ash) in the USA (EUR 92 million);<br />
– the capital gain (EUR 30 million) on the sale of <strong>Solvay</strong><br />
Engineered Polymers in the USA;<br />
– non-recurring restructuring charges in the<br />
Pharmaceuticals Sector (EUR 48 million for the<br />
“INSPIRE” project) and the Chemicals Sector<br />
(EUR 12 million asset depreciation as part of the<br />
restructuring of the Girindus activities in Germany).<br />
Charges on net indebtedness (EUR 93 million) were<br />
higher than in 2007, in line with the increase in net average<br />
indebtedness. At the end of December 2008, 95% of the<br />
fi nancial debt was covered at an average fi xed rate of<br />
5.4% for a duration of 7.4 years. The fi rst signifi cant debt<br />
maturity will not occur until 2014.<br />
Income from investments included the extraordinary<br />
write-down (EUR -309 million) of holdings in Fortis<br />
(non-cash charge), posted at closing at the end of 2008<br />
(EUR 0.929 per share). This holding was acquired by<br />
the Group between the two world wars. More recently, it<br />
generated capital gains close to EUR 200 million (in 1998<br />
and 2007) and a dividend of EUR 20 million in 2007.<br />
Income Taxes amounted to EUR -143 million.<br />
The effective tax rate is 24% compared with 29% in 2007.<br />
The 2008 tax rate benefi ted from the reversal of provisions<br />
following the favorable outcome of tax inspections and the<br />
write up of earlier tax losses, but was negatively affected<br />
by the non-deductible write down of holdings in Fortis.<br />
Net income of the Group (EUR 449 million) is down<br />
46% on 2007. Minority interests are EUR 44 million<br />
compared with EUR 47 million in 2007. Net earnings per<br />
share is EUR 4.92 in 2008 (as against EUR 9.46 in 2007).<br />
REBITDA<br />
REBITDA amounted to EUR 1 436 million. Recurrent<br />
depreciation and amortization were stable compared<br />
with 2007. Total depreciation and amortization<br />
(EUR 417 million) were down 30% with the reversal of<br />
the impairment on the trona mine (natural soda ash) and<br />
the recording in 2007 of non-recurrent write-offs linked to<br />
the restructuring in the Fluorinated and Pharmaceuticals<br />
activities.<br />
(EUR million)<br />
1750<br />
1400<br />
1050<br />
700<br />
350<br />
0<br />
1 146<br />
2004<br />
1 338<br />
2005<br />
1 568<br />
2006<br />
1 662<br />
2007<br />
1 436<br />
2008